Efficacy and applications for PuraStat® use in the management of unselected gastrointestinal bleeding: A retrospective observational study

Table 2 Outcome in whole cohort and in the subgroup with upper gastrointestinal bleeding, n (%)

	Mortality yes/no	P value
All patients outcome, n = 45
PuraStat® alone	2 (12.5)/14 (87.5)	0.69
In combination	6 (20.7)/23 (79.3)
Blood transfusion
Yes	8 (30.8)/18 (69.2)	0.014
No	0 (0.0)/19 (100)
Rebleeding
Yes	4 (80)/1 (20)	0.002
No	4 (10)/36 (90)
Charlson score (mean ± SD)	4.67 ± 2.8/2.69 ± 2.0	0.081
Charlson score
≤ 2	0 (0.0)/18 (100)	0.01
> 2	8 (29.8)/19 (70.2)
Subgroup UGIB n = 35
PuraStat® alone	2 (14.3)/12 (85.7)	0.43
In combination	6 (28.6)/15 (71.4)
Charlson score		0.046
≤ 2	0 (0.0)/13 (100)
> 2	8 (36.4)/14 (63.6)

UGIB: Upper gastrointestinal bleeding.